| Literature DB >> 32998031 |
Tamotsu Maruyama1, Mutsumi Sugii1, Daiki Omata1, Johan Unga1, Tadamitsu Shima1, Lisa Munakata1, Saori Kageyama1, Fumiko Hagiwara1, Yuno Suzuki1, Kazuo Maruyama2, Ryo Suzuki3.
Abstract
Diagnostic ultrasound is non-invasive and provides real-time imaging. Microbubbles (MBs) are ultrasound contrast agents used to observe small blood flow, such as tumor tissue. However, MBs have short blood flow imaging time. This study developed lipid-based microbubbles (LMBs) with longer blood flow imaging time by focusing on their shell composition. Liposome research reported that addition 1,2-distearoyl-sn-glycero-3-phosphoglycerol (DSPG) to the lipid composition enhances liposome membrane stability. Therefore, we introduced DSPG at different ratios into the LMBs lipid shell. Results showed that the lipid shell composition of MBs affects stability in vivo. 60% DSPG-containing LMBs (DSPG60-LMBs) have sustained blood flow imaging time compared with LMBs, which have other DSPG ratios, Sonazoid® and SonoVue®. DSPG60-LMBs also showed less uptake into the liver compared with Sonazoid®. Therefore, DSPG60-LMBs can have long blood flow imaging time and can be effective diagnostic agents in ultrasound imaging.Entities:
Keywords: Blood flow imaging; DSPG; Diagnostics; Microbubbles; Ultrasound contrast agent
Mesh:
Substances:
Year: 2020 PMID: 32998031 DOI: 10.1016/j.ijpharm.2020.119886
Source DB: PubMed Journal: Int J Pharm ISSN: 0378-5173 Impact factor: 5.875